Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome.

@article{Uriz2000TerlipressinPA,
  title={Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome.},
  author={Juan Uriz and Pere Gin{\`e}s and Andres Cardenas and Pau Sort and Wladimiro Jim{\'e}nez and Juan Manuel Salmer{\'o}n and Ram{\'o}n Bataller and Antoni Gelabert Mas and Miquel Angel Navasa and Vicente Arroyo and J. J. Rodes},
  journal={Journal of hepatology},
  year={2000},
  volume={33 1},
  pages={43-8}
}
BACKGROUND/AIM Ornipressin, a vasopressin analog with potent splanchnic vasoconstrictor action, has been shown to reverse hepatorenal syndrome. However, its usefulness in clinical practice is limited by frequent ischemic complications. The aim of this study was to assess the efficacy of terlipressin, an analog of vasopressin with a low profile of side effects, plus albumin in this condition. METHODS Nine consecutive patients with cirrhosis and hepatorenal syndrome were included in a pilot… CONTINUE READING
105 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 105 extracted citations

Similar Papers

Loading similar papers…